What is the current Price Target for the Angion Biomedica Corp stock?

The average Angion Biomedica Corp target price is $9.00. This is 80.00% higher than the current stock price. 1 Analyst has issued a Angion Biomedica Corp price target 2025.

How high will the Angion Biomedica Corp stock rise?

No reliable answer can be given as to how high the Angion Biomedica Corp stock will rise. The performance of stocks, including the Angion Biomedica Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Angion Biomedica Corp stock today?

The performance of Angion Biomedica Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Angion Biomedica Corp stock fall?

The decline in Angion Biomedica Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Angion Biomedica Corp Forecast, price target & analysts

$5.00

2.91%

Nasdaq, Mon, Dec 30 2024

ISIN

US03476J1079

Symbol

ANGN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Angion Biomedica Corp Target price 2024 - Analyst rating & recommendation

Angion Biomedica Corp Classifications & Recommendation:

Buy

50%

Hold

50%

Angion Biomedica Corp Price Target

Target Price	$9.00
Price	$5.00
Potential	80.00% register free of charge
Number of Estimates	1

	1 Analyst has issued a Angion Biomedica Corp price target 2025. The average Angion Biomedica Corp target price is $9.00. This is 80.00% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 1 Analysts recommend Angion Biomedica Corp to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Angion Biomedica Corp stock has an average upside potential 2025 of 80.00% register free of charge . Most analysts recommend the Angion Biomedica Corp stock at Buy or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-6.96	-3.96
	99.22%	43.10%
P/E		negative

1 Analysts have issued a Angion Biomedica Corp forecast for earnings per share. The average Angion Biomedica Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-6.96	99.22%
2024	$-3.96 43.10% Unlock
2025	$-1.78 55.05% Unlock
2026	$-1.21 32.02% Unlock
2027	$-1.24 2.48% Unlock
2028	$-1.14 8.06% Unlock

Current	-1.25	4,066.67%
2024	-1.30 4.00% Unlock
2025	-2.89 122.31% Unlock
2026	-4.26 47.40% Unlock
2027	-4.15 2.58% Unlock
2028	-4.52 8.92% Unlock

Angion Biomedica Corp...

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 117.96%

Moderna 81.31%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now